Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation

ANZ Journal of Surgery

Volumn 77, Issue 5, 2007, Pages 314-319

  Suthers, Graeme K ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Breast cancer; Ovarian cancer; Risk

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BRCA2 GENE; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; NORTH AMERICA; ONCOGENE; OVARY CARCINOMA; PREMENOPAUSE;

ADULT; AGE FACTORS; AGED; AUSTRALIA; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS;

EID: 34248203711     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2007.04050.x     Document Type: Article

References (11)

1. Phillips KA, Jenkins MA, Lindeman GJ et al. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. kConFab Investigators. Clin. Genet. 2006 70 : 198 206.
2. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994 343 : 692 5.
3. Hopper JL, Southey MC, Dite GS et al. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol. Biomarkers Prev. 1999 8 : 741 7.
4. Scott CL, Jenkins MA, Southey MC et al. Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum. Genet. 2003 112 : 542 51.
5. Chen S, Iversen ES, Friebel T et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J. Clin. Oncol. 2006 24 : 863 71.
6. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002 2 : 37.
7. Australian Institute of Health and Welfare. Canberra : Australian Institute of Health and Welfare, 2006. [Cited 4 Dec 2006.] Available from URL : www.aihw.gov.au
8. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br. J. Cancer 2000 83 : 1301 8.
9. Contant CM, Menke-Pluijmers MB, Seynaeve C et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Eur. J. Surg. Oncol. 2002 28 : 627 32.
10. Chlebowski RT. Breast cancer risk reduction: strategies for women at increased risk. Annu. Rev. Med. 2002 53 : 519 40.
11. Simchoni S, Friedman E, Kaufman B et al. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc. Natl. Acad. Sci. USA 2006 103 : 3770 74.